Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.9.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.76NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.107NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LF.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.172NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.110NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.320NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.91NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KB.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.51.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDD.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.526 (Iota)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.621 (Mu)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.9.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.43.4 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.57 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.7 (Alpha)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-19361.6US
AY.120.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.119.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.121 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.14 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.119 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.46.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.114 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used